FdaApplication
NDA 216665
Identifiers
- fda_app_no: NDA216665
Properties
| Property | Value |
|---|---|
| applicant_name | SOLENO |
| application_type | NDA |
| approval_date | 2025-03-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VYKAT XR | DIAZOXIDE CHOLINE | 25MG | TABLET, EXTENDED RELEASE;ORAL |
| VYKAT XR | DIAZOXIDE CHOLINE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| VYKAT XR | DIAZOXIDE CHOLINE | 75MG | TABLET, EXTENDED RELEASE;ORAL |
3 products